Skip to content

Clinical trials

Completed Multiple Sclerosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Netherlands Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20064
20075
20083
20096
20102
20114
20125
20134
20144
20152
20162
20183
20202
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen13
Bayer6
Genzyme, a Sanofi Company4
Novartis Pharmaceuticals4
Sanofi4
Actelion2
Amsterdam UMC, location VUmc2
GlaxoSmithKline2
Hoffmann-La Roche2
Merck KGaA, Darmstadt, Germany2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis57
Multiple Sclerosis, Relapsing-Remitting9
Recurrence6
Fatigue3
Brain Injuries, Traumatic1
Disease Progression1
Multiple Sclerosis, Chronic Progressive1
Sleep Initiation and Maintenance Disorders1
Spinal Cord Diseases1
Spinal Cord Injuries1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.